Impact of tumor infiltrating lymphocytes (TILs) on local progression-free (LPFS) and disease-free (DFS) survival in localized high-risk soft tissue sarcoma (HR-STS) after neo-adjuvant chemotherapy (NAC) with regional hyperthermia (RHT)

被引：0
|
作者：
Issels, R. D. [1 ]
Kampmann, E. [1 ]
Buecklein, V. [1 ]
Noessner, E. [2 ]
Lindner, L. H. [1 ]
Schmidt, M. [3 ]
Mansmann, U. [3 ]
Hiddemann, W. [1 ]
Subklewe, M. [1 ]
Knoesel, T. [4 ]
机构：
[1] Univ Munich, Univ Hosp Grosshadern, Dept Med 3, Munich, Germany
[2] Helmholtz Zentrum Munchen, Germany Res Ctr Environm Hlth, Inst Mol Immunol, Munich, Germany
[3] Univ Munich, Inst Med Informat Biostat & Epidemiol, Munich, Germany
[4] Univ Munich, Inst Pathol, D-80539 Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9PD
引用
收藏
页码：3 / 3
页数：1
相关论文
共 12 条
  • [1] NEO-ADJUVANT CHEMOTHERAPY WITH REGIONAL HYPERTHERMIA (RHT)FOR LOCALIZED HIGH-RISK SOFT-TISSUE SARCOMA (HR-STS) WITH ABDOMINAL/RETROPERITONEAL LOCATION
    Issels, R. D.
    Lindner, L. H.
    Reichardt, P.
    Schem, B.
    Wendtner, C.
    Wessalowski, R.
    Jauch, K.
    Mansmann, U.
    Blay, J.
    Hohenberger, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 411 - 411
  • [2] IMPROVEMENT OF LOCAL PROGRESSION (LPFS) AND DISEASE-FREE SURVIVAL (DFS) BY REGIONAL HYPERTHERMIA (RHT) COMBINED WITH NEO-ADJUVANT CHEMOTHERAPY IN NON-EXTREMITY (NE) HIGH-RISK SOFT-TISSUE SARCOMA (HR-STS) WITH COMPLETE (R0/R1) SURGICAL RESECTION
    Issels, R. D.
    Lindner, L.
    Laubender, R.
    Klose, C.
    Mansmann, U.
    Reichardt, P.
    Schem, B. C.
    Wendtner, C. M.
    Wessalowski, R.
    Gattermann, N.
    Jauch, K. W.
    Blay, J. Y.
    Hohenberger, P.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S170 - S170
  • [3] Dissecting the role of tumor-infiltrating lymphocytes (TIL) in patients with high-risk soft-tissue sarcoma (STS) receiving neo-adjuvant chemotherapy (NAC) with regional hyperthermia (RHT)
    Issels, R.
    Bueclein, V.
    Kampmann, E.
    Knoesel, T.
    Noessner, E.
    Subklewe, M.
    Lindner, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Effect of regional hyperthermia (RHT) in combination with neo-adjuvant chemotherapy for treatment of locally advanced high-risk soft-tissue sarcoma (HR-STS) is not dependent on etoposide
    Chuebbe, G. -E.
    Karopmanni, E.
    Aubele, P.
    Dieterlei, N.
    Abdel-Rahman, S.
    Ulrich, M.
    Issels, R. D.
    Lindner, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 38 - 38
  • [5] Impact of regional hyperthermia (RHT) on response to neo-adjuvant chemotherapy and survival of patients with high-risk soft-tissue sarcoma (HR-STS): Results of the randomized EORTC-ESHO intergroup trial (NCI-00003052)
    Issels, R.
    Lindner, L. H.
    Wendtner, C. M.
    Hohenberger, P.
    Reichardt, P.
    Daugaard, S.
    Mansmann, U.
    Hiddemann, W.
    Blay, J. Y.
    Verweij, J.
    EJC SUPPLEMENTS, 2009, 7 (03): : 2 - 2
  • [6] Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study
    Issels, R. D.
    Lindner, L. H.
    Ghadjar, P.
    Reichardt, P.
    Hohenberger, P.
    Verweij, J.
    Abdel-Rahman, S.
    Daugaard, S.
    Salat, C.
    Vujaskovic, Z.
    Wessalowski, R.
    Duerr, H. R.
    Ploner, F.
    Mella, O.
    Schmidt, M.
    Mansmann, U.
    Jauch, K. W.
    Belka, C.
    Hiddemann, W.
    Gronchi, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S716 - S716
  • [7] COMPARISON OF TWO CHEMOTHERAPY REGIMENS (AI VS. EIA) COMBINED WITH REGIONAL HYPERTHERMIA (RHT) IN HIGH-RISK SOFT-TISSUE SARCOMA (HR-STS)
    Aubele, P. O.
    Kampmann, E.
    Schuebbe, G.
    Abdel-Rahman, S.
    Dieterle, N.
    Laubender, R.
    Issels, R.
    Lindner, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 487 - 487
  • [8] Initial response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) In high-risk soft tissue sarcomas (HR-STS) of adults and its correlation to survival parameters
    Issels, RD
    Abdel-Rahman, S
    Falk, MH
    Salat, C
    Ochmann, O
    Reiser, M
    Hiddemann, W
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S266 - S266
  • [9] PET response criteria (PERCIST) predict progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma
    Fendler, Wolfgang
    Lehmann, Mona
    Todica, Andrei
    Knoesel, Thomas
    Duerr, Hans
    Rauch, Josefine
    Bartenstein, Peter
    Cyran, Clemens
    Hacker, Marcus
    Lindner, Lars
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [10] Early response to neoadjuvant chemotherapy (NAC) in combination with regional hyperthermia (RHT) to predict long-term survival for adult-type high-risk soft tissue sarcoma (HR-STS): Results of the EORTC-ESHO intergroup phase III study.
    Issels, Rolf D.
    Kampmann, Eric
    Lindner, Lars
    Dieterle, Nelli
    Mansmann, Ulrich Robert
    Verweij, Jaap
    Kirchner, Thomas
    Wendtner, Clemens Martin
    Wessalowski, Ruediger
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12